← All trials
NCT07110831
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 14, 2025
- Primary completion
- Sep 30, 2027
- Completion date
- Mar 31, 2028
- First posted
- Aug 8, 2025
- Last posted
- Aug 8, 2025
- Enrollment
- 168
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of IbadanLead sponsor
- University of IbadanOfficial
- State University of New York, BuffaloCollaborator
- State University of New York, BuffaloCollaborator
- National Institutes of Health (NIH)Collaborator
- National Institute of Mental Health (NIMH)Collaborator
- University of IbadanSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.